2022 年 10 月 24 日

Calyx IRT 提供灵活性以加速招募

Advanced IRT system enhanced with self-service functionality to quickly address trial challenges

Nottingham, England and Morrisville, NC – 2022 年 10 月 24 日 Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data challenges in clinical research, today announced a significant enhancement to its advanced interactive response technology (IRT) system. Calyx has expanded its self-service IRT tools, which enable clinical trial sponsors and CROs to quickly adapt to trial needs without reprogramming.

With the ability to easily add countries and depots to Calyx IRT’s customizable platform, sponsors can react to the inevitable changing needs of their trials and quickly have medication available for patient enrolments at new sites worldwide.

“Facing tighter than ever timelines, most sponsors expand their trials to additional countries at least once, if not multiple times during clinical trials in order to meet patient recruitment goals,” said Juan Munoz Pujol, Vice President of IRT at Calyx. “This new functionality gives sponsors the flexibility they need to easily change their core IRT settings as often as circumstances require to quickly activate sites in new countries and accelerate patient recruitment. We believe this benefit will be reflected in faster timelines and lower costs.”

Click here for more information on how Calyx IRT self-service tools and other advanced functionality drives clinical trial success.

关于凯理斯

凯理斯是一家全球顶尖的医学影像及临床信息化管理供应商,提供包括独立中心影像评估(IRC)、随机化和药品供应管理系统及服务(IRT)、临床试验管理系统(CTMS) 、临床试验电子数据采集系统(EDC)、eCTD递交及临床法规信息系统(RIM)等全面解决方案。 凯理斯服务申办方和临床研究组织 (CRO)已经近三十年,支持多达 60,000 项试验,成功帮助申办方通过了 650 个新药审批,惠及1,800 万名患者。经过近10年在中国新药研发行业的深耕,凯理斯中国团队已逾百人;通过全面深入的本土化,目前已服务近120家本土企业,同时和国内近10家顶尖药企及创新药公司达成企业级长期战略合作。

医学影像 | IRT | CTMS | EDC | RIM

Take your trials further with intelligent insights at Calyx.ai or at LinkedIn, Twitter, or Facebook.

联系人:

Christine Tobin | christine.tobin@calyx.ai | +1 412-628-8598


获取最新消息

不错过任何精彩内容。立即注册,接收涵盖行业新闻和其他相关信息的电子邮件,帮助您推进临床开发。

  • 此字段用于验证目的,应保持不变。
Powered by Translations.com GlobalLink OneLink Software